Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Treatment
Share your love
Blepharoconjunctivitis: Causes, Symptoms and Treatment
Blepharoconjunctivitis is a medical condition characterized by the simultaneous inflammation of the eyelids (blepharitis) and the conjunctiva, which is the membrane covering the white part of the eye and the inner surface of the eyelids. This condition often results in…
Scientist Awarded $300K for AMD Research
Dr. Rajendra Apte, MD, PhD, has been honored with the Research to Prevent Blindness (RPB)/American Macular Degeneration Foundation (AMDF) Catalyst Award for Innovative Research Approaches for Age-Related Macular Degeneration (AMD). This award, amounting to $300,000, underscores Dr. Apte’s dedication and…
FDA Approves XDEMVY for Demodex Blepharitis
Tarsus Pharmaceuticals has received FDA approval for XDEMVY(TM) (lotilaner ophthalmic solution) 0.25% to treat Demodex blepharitis, making it the first and only FDA-approved treatment directly targeting Demodex mites, the underlying cause of the condition. The approval was based on the…
Lupin Launches Bromfenac Ophthalmic Solution in the US
Lupin Limited announced the launch of Bromfenac Ophthalmic Solution, 0.075%. The product has received the green light from the United States Food and Drug Administration (U.S. FDA), marking a crucial milestone for the company’s expansion in the American pharmaceutical market.…
Opthea Completes Enrollment for Wet AMD Trial
Opthea has reached a significant milestone in its quest to combat wet age-related macular degeneration (AMD) with the completion of patient enrollment in the COAST phase 3 pivotal clinical trial. The trial investigates sozinibercept (OPT-302), a promising vascular endothelial growth…
Dry Eye Treatment & Cyclosporine and Side Effect in Dogs
Dry eye disease (DED), also known as keratoconjunctivitis sicca (KCS), is a common disorder of the eye affecting millions of people around the world. The prevalence of DED ranges from 5% to 33% worldwide with increased prevalence among adult women…
ESCRS 2023 Recap: Biotech Companies That Stand Out
As OBN, we had the privilege of participating in the ESCRS Congress 2023 held in Vienna, where we witnessed the remarkable efforts of various companies dedicated to enhancing patient outcomes. In this exclusive article, we present a compilation of ten…
What is Penetrating Keratoplasty and How to Perform it
What is Penetrating Keratoplasty? Penetrating Keratoplasty (PKP), also known as a full-thickness corneal transplant, is a significant ophthalmic surgical procedure aimed at restoring visual acuity in patients with corneal diseases. This procedure involves the replacement of the entire corneal tissue…
What Is Corneal Collagen Cross-Linking?
The world of ophthalmology is constantly evolving, with innovative treatments and procedures emerging to address a wide range of eye conditions. One such cutting-edge treatment, corneal collagen cross-linking (CXL), has gained significant attention for its role in managing keratoconus, a…
Lotilaner Shows Promise for Treating Demodex Blepharitis
A team of investigators, led by Elizabeth Yeu, MD, from Virginia Eye Consultants in Norfolk, Virginia, reported the safety and efficacy of lotilaner ophthalmic solution, 0.25% (TP-03, Tarsus Pharmaceuticals Inc.), in treating Demodex blepharitis. Demodex mites are the most common…